Comorbidities associated with 30-day readmission following index coronavirus disease 2019 (COVID-19) hospitalization: A retrospective cohort study of 331,136 patients in the United States.

Gita NadimpalliLyndsay M O'HaraLaurence S MagderJ Kristie JohnsonAbdolreza HaririanLisa PinelesKatherine E Goodman Jonathan D BaghdadiBeth L PinelesAnthony D Harris

Published in: Infection control and hospital epidemiology (2022)

Readmission within 30 days was common among COVID-19 survivors. A better understanding of comorbidities associated with readmission will aid hospital care teams in improving postdischarge care. Additionally, it will assist hospital epidemiologists and quality administrators in planning resources, allocating staff, and managing bed-flow issues to improve patient care and safety.

Keyphrases

coronavirus disease
healthcare
sars cov
end stage renal disease
quality improvement
palliative care
chronic kidney disease
ejection fraction
newly diagnosed
young adults
pain management
prognostic factors
acute care
emergency department
peritoneal dialysis
adverse drug
affordable care act
chronic pain
drug induced